Search results
Pages
-
- Real-world outcomes of ipilimumab plus nivolumab combination therapy in a nationwide cohort of advanced melanoma patients in the Netherlands
-
- A survival tree of advanced melanoma patients with brain metastases treated with immune checkpoint inhibitors
-
- Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies
-
- Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma
-
- Failure to validate existing clinical prediction scale for response to PD-1 monotherapy in advanced melanoma in national cohort study
-
- Association of immune-related adverse event management with survival in patients with advanced melanoma
-
- Is a history of optimal staging by sentinel lymph node biopsy in the era prior to adjuvant therapy associated with improved outcome once melanoma Patients have progressed to advanced disease?